Company Progenics Pharmaceuticals, Inc.
Equities
US7431871067
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 08/19/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Mims
CEO | Chief Executive Officer | 60 | 08/19/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 86,796,000 | 85,730,040 ( 98.77 %) | 200,000 ( 0.2304 %) | 98.77 % |
Company contact information
Progenics Pharmaceuticals, Inc.
One World Trade Center 47th floor
10007-0089, New York
+
http://www.progenics.comSector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |